Peter Collins is Professor of Clinical Cardiology, National Heart and Lung Institute, Imperial College London, and Honorary Consultant Cardiologist at the Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust.
Professor Collins was an undergraduate at Caius College, Cambridge University before moving to St Thomas’ Hospital Medical School. He conducted his research for an MD degree at the University Hospital of Wales, Cardiff, receiving his MD degree from the University of Cambridge, and won the University’s Sir Walter Langdon-Brown prize for the thesis. He was appointed Consultant Cardiologist in 1989 and appointed Professor of Clinical Cardiology at Imperial College in 2001. He is responsible for the education and training of specialist cardiology trainees at the Royal Brompton and Harefield NHS Foundation Trust and runs the undergraduate cardiology medical course for final year medical students for Imperial College at the Royal Brompton campus. He chairs the Final Year Cardiology course committee at Imperial College and the Education and Training board at the Royal Brompton and Harefield NHS Foundation Trust.
Professor Collins is a Fellow of the Royal College of Physicians of London, the American College of Cardiology, the European Society of Cardiology. He is a member of the British Cardiac Society and the prestigious Association of Physicians of Great Britain and Ireland. He is and has been a member and board member of several renowned societies and committees such as the International Menopause Society, British Menopause Society and European Society of Cardiology. He is currently the Chairman of the newly formed Task Force on Gender of the European Society of Cardiology.
His principle clinical interests are in cardiovascular disease and in particular cardiovascular disease in women, coronary heart disease, hypertension, hyperlipidaemia, insulin resistance and diabetes. He has been instrumental in setting up and running the ‘Women’s Heart Clinic’ at the Royal Brompton Hospital, one of the first of its kind in the UK.
Professor Collins’ research interests include coronary flow control mechanisms, both in normal and disease states including ischemic heart disease, hypertension and heart failure, and the role of the endothelium in cardiovascular physiology and pathophysiology. His research on the endothelium led to work investigating the vascular effects of a number of different hormones including, oestrogens, progestins, androgens, SERMS and phytoestrogens, to identify the mechanisms of action and effects of these hormones in the cardiovascular system. He has extensively researched the rare but complex condition known as cardiac Syndrome X, a condition of troublesome chest pain in the absence of coronary heart disease, and has established a number of new treatment modalities for this difficult-to-manage syndrome.
Professor Collins has supervised numerous research students, many of whom are now consultant cardiologists, and has published extensively in many international peer-reviewed journals. He is the co-Editor of ‘Women and Heart Disease’, and recently has been responsible for the publication of a cardiovascular risk factor guide for menopause physicians in an attempt to improve the awareness, and aid with the management, of cardiovascular risk factors in menopausal women.
et al., 2016, Cardiovascular risk assessment in women - an update, Climacteric, Vol:19, ISSN:1369-7137, Pages:329-336
et al., 2016, Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis, Bmj-british Medical Journal, Vol:353, ISSN:1756-1833
et al., 2015, Serial Changes in High-Sensitivity Cardiac Troponin, N-terminal Pro-B-Type Natriuretic Peptide, and Heart Fatty Acid Binding Protein during Exercise Echocardiography in Patients with Suspected Angina Pectoris and Normal Resting Left Ventricular Function, Clinical Chemistry, Vol:61, ISSN:0009-9147, Pages:554-556
et al., 2014, NOAC in acute coronary syndrome and AF?, Cardiovasc Hematol Disord Drug Targets, Vol:14, Pages:154-164
et al., 2014, CHARACTERISATION OF DIFFERING IN VITRO THROMBOTIC PROFILES IN AF AND CORONARY DISEASE: ROLE OF ENDOGENOUS THROMBOLYSIS, Journal of the American College of Cardiology, Vol:63, ISSN:0735-1097, Pages:A467-A467